Polar Capital Global Healthcare Trust (LSE:PCGH) ROE %: 12.39% (As of Mar. 2026) — 33% Above Median


LSE:PCGH Polar Capital Global Healthcare Trust PLC LSE:PCGH
54 GF Score
Price £4.38
GF Value £9.07
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Polar Capital Global Healthcare Trust ROE %?

Polar Capital Global Healthcare Trust LSE:PCGH +1.86% 54 ROE % is 12.39% as of Mar. 2026, which is 33% above its 10-year median of 9.29. GuruFocus rates LSE:PCGH with a GF Score™ of 54/100 and a GF Value™ of £9.07 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 1,612 Asset Management companies, Polar Capital Global Healthcare Trust ranks better than 66.81% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Polar Capital Global Healthcare Trust's annualized net income for the quarter that ended in Mar. 2026 was £51.10 Mil. Polar Capital Global Healthcare Trust's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was £412.58 Mil. Therefore, Polar Capital Global Healthcare Trust's annualized ROE % for the quarter that ended in Mar. 2026 was 12.39%.

The historical rank and industry rank for Polar Capital Global Healthcare Trust's ROE % or its related term are showing as below:

LSE:PCGH' s ROE % Range Over the Past 10 Years
Min: -6.05   Med: 9.29   Max: 18.62
Current: 11.14

During the past 13 years, Polar Capital Global Healthcare Trust's highest ROE % was 18.62%. The lowest was -6.05%. And the median was 9.29%.

LSE:PCGH's ROE % is ranked better than
66.81% of 1612 companies
in the Asset Management industry
Industry Median: 6.395 vs LSE:PCGH: 11.14

Polar Capital Global Healthcare Trust  (LSE:PCGH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=51.1/412.582
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(51.1 / 53.194)*(53.194 / 437.7355)*(437.7355 / 412.582)
=Net Margin %*Asset Turnover*Equity Multiplier
=96.06 %*0.1215*1.061
=ROA %*Equity Multiplier
=11.67 %*1.061
=12.39 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=51.1/412.582
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (51.1 / 52.198) * (52.198 / 53.194) * (53.194 / 437.7355) * (437.7355 / 412.582)
= Tax Burden * Pretax Margin % * Asset Turnover * Equity Multiplier
= 0.979 * 98.13 % * 0.1215 * 1.061
=12.39 %

Note: The net income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Polar Capital Global Healthcare Trust ROE % Related Terms


Polar Capital Global Healthcare Trust ROE % Historical Data

* Premium members only.

The historical data trend for Polar Capital Global Healthcare Trust's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polar Capital Global Healthcare Trust ROE % Chart

Polar Capital Global Healthcare Trust Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.73 5.45 4.10 13.98 -6.05

Polar Capital Global Healthcare Trust Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.69 -2.80 -21.63 9.59 12.39

LSE:PCGH vs BLK, BX, KKR: ROE % Comparison

For the Asset Management subindustry, Polar Capital Global Healthcare Trust's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polar Capital Global Healthcare Trust ROE % vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Polar Capital Global Healthcare Trust's ROE % distribution charts can be found below:

* The bar in red indicates where Polar Capital Global Healthcare Trust's ROE % falls into.


LSE:PCGH
54GF Score
Polar Capital Global Healthcare Trust PLC LSE:PCGH
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Polar Capital Global Healthcare Trust ROE % Calculation

Polar Capital Global Healthcare Trust's annualized ROE % for the fiscal year that ended in Sep. 2025 is calculated as

ROE %=Net Income (A: Sep. 2025 )/( (Total Stockholders Equity (A: Sep. 2024 )+Total Stockholders Equity (A: Sep. 2025 ))/ count )
=-28.053/( (479.073+448.11)/ 2 )
=-28.053/463.5915
=-6.05 %

Polar Capital Global Healthcare Trust's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Sep. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=51.1/( (448.11+377.054)/ 2 )
=51.1/412.582
=12.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 12.39% mean?
Polar Capital Global Healthcare Trust (LSE:PCGH) has a ROE % of 12.39% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Polar Capital Global Healthcare Trust and its competitors. This is 33% above median its historical median of 9.29. According to the industry distribution chart, Polar Capital Global Healthcare Trust ranks #535 out of 1612 companies in the Asset Management industry, placing it in the top 33.2%.
Is Polar Capital Global Healthcare Trust's ROE % too high?
Polar Capital Global Healthcare Trust's current ROE % of 12.39% is 33% above median its 10-year median of 9.29. The Asset Management industry median ROE % is 6.40. Polar Capital Global Healthcare Trust's value of 12.39% is 93.7% above this industry median. Based on the distribution chart, Polar Capital Global Healthcare Trust ranks #535 out of 1612 companies in the Asset Management industry, which is above the industry midpoint. Overall, Polar Capital Global Healthcare Trust has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Polar Capital Global Healthcare Trust's ROE % compare to BLK and BX?
According to the Asset Management industry distribution chart, Polar Capital Global Healthcare Trust ranks #535 out of 1612 companies for ROE %. This puts Polar Capital Global Healthcare Trust in the upper half of its industry. The industry median ROE % is 6.40. Polar Capital Global Healthcare Trust's value of 12.39% is 93.7% above this benchmark. While the company's 10-year median is 9.29 vs. the industry median of 6.40, Polar Capital Global Healthcare Trust has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Asset Management company?
The median ROE % among Asset Management companies is 6.40, based on 1,612 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polar Capital Global Healthcare Trust's current ROE % of 12.39% is 93.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Polar Capital Global Healthcare Trust and its competitors. For the Asset Management industry, the median ROE % is 6.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polar Capital Global Healthcare Trust's current ROE % is 12.39%, which is 33% above median its own 10-year median of 9.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polar Capital Global Healthcare Trust stock overvalued right now?
Based on GuruFocus' analysis, Polar Capital Global Healthcare Trust (LSE:PCGH) is currently considered Significantly Undervalued. The stock's GF Value™ is £9.07, compared to a current price of £4.38 — trading 51.7% below its estimated fair value. The current ROE % is 12.39%, which is 33% above median its 10-year median of 9.29 and 93.7% above the Asset Management industry median of 6.40. Polar Capital Global Healthcare Trust's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Polar Capital Global Healthcare Trust (LSE:PCGH), the current ROE % is 12.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Polar Capital Global Healthcare Trust (LSE:PCGH) Overvalued in 2026?

Based on GuruFocus' analysis, Polar Capital Global Healthcare Trust stock appears to be undervalued. The current stock price of £4.38 is trading 51.7% below its estimated GF Value™ of £9.07. GuruFocus considers Polar Capital Global Healthcare Trust to be Significantly Undervalued.

Key valuation signals for LSE:PCGH:

  • ROE %: 12.39% (33% above median its 10-year median of 9.29)
  • GF Value™: £9.07 vs. price of £4.38 (51.7% below fair value)
  • GF Score™: 54/100 with 4 warning signs
  • Industry Position: 93.7% above the Asset Management median (#535 of 1612)

No single metric tells the full story. See the LSE:PCGH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Polar Capital Global Healthcare Trust Business Description

Address 16 Palace Street, London, GBR, SW1E 5JD
Polar Capital Global Healthcare Trust PLC is a United Kingdom-based investment trust company. The company's investment objective is the generation of capital growth through investments in a portfolio of healthcare stocks. The purpose of the company is to provide an investment vehicle for investors which aims to deliver long term capital growth to shareholders from a range of diversified healthcare stocks.
54GF Score

Get the complete analysis for LSE:PCGH

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£4.38
Price
£9.07
GF Value